Friday, April 29th, 2016

Amgen Inc. Therapeutics and Drug Pipeline Review H1 2016

Summary adds “Amgen Inc. Therapeutics and Drug Pipeline Review H1 2016” report to its research database.

Global Markets Direct’s, ‘Amgen Inc. - Product Pipeline Review - 2016’, provides an overview of the Amgen Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Amgen Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Complete report in Detailed @

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the pipeline therapeutic landscape of Amgen Inc. 
- The report provides overview of Amgen Inc. including its business description, key facts, and locations and subsidiaries 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Amgen Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Amgen Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Amgen Inc.’s strategic position with total access to detailed information on its product pipeline 
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Amgen Inc. 
- Identify potential new clients or partners in the target demographic 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Amgen Inc.’s pipeline depth and focus of pipeline therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Get the best Discount @


List of Tables 
Amgen Inc., Key Information 14 
Amgen Inc., Key Facts 14 
Amgen Inc. - Pipeline by Indication, 2016 16 
Amgen Inc. - Pipeline by Stage of Development, 2016 23 
Amgen Inc. - Monotherapy Products in Pipeline, 2016 24 
Amgen Inc. - Partnered Products in Pipeline, 2016 25 
Amgen Inc. - Partnered Products/ Combination Treatment Modalities, 2016 26 
Amgen Inc. - Out-Licensed Products in Pipeline, 2016 27 
Amgen Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 28 
Amgen Inc. - Pre-Registration, 2016 30 
Amgen Inc. - Filing rejected/Withdrawn, 2016 31 
Amgen Inc. - Phase III, 2016 32 
Amgen Inc. - Phase II, 2016 33 
Amgen Inc. - Phase I, 2016 34 
Amgen Inc. - Preclinical, 2016 36 
Amgen Inc. - Discovery, 2016 39 
Amgen Inc. - Pipeline by Target, 2016 170 
Amgen Inc. - Pipeline by Route of Administration, 2016 175 
Amgen Inc. - Pipeline by Molecule Type, 2016 176 
Amgen Inc. - Pipeline Products by Mechanism of Action, 2016 177 
Amgen Inc. - Recent Pipeline Updates, 2016 181 
Amgen Inc. - Dormant Developmental Projects,2016 232 
Amgen Inc. - Discontinued Pipeline Products, 2016 236 
Amgen Inc., Other Locations 244 
Amgen Inc., Subsidiaries 246 
Amgen Inc., Key Manufacturing Facilities 249

Sample Page of the Report @


Contact US:                   


Partner Relations & Marketing Manager

[email protected]   

Ph: +1-646-845-9349 (US)      

Ph: +44 208 133 9349 (UK)

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Amgen Inc. Therapeutics, Amgen Inc. Therapeutics Industry,  Amgen Inc. Therapeutics Market, Amgen Inc. Therapeutics Market Trends, Amgen Inc. Therapeutics Industry Trends, Amgen Inc. Therapeutics Market Share, Amgen Inc. Therapeutics  Market Growth, Amgen




More Formats

View QR Code